293 related articles for article (PubMed ID: 26945671)
1. Structural characterization of the C-terminal coiled-coil domains of wild-type and kidney disease-associated mutants of apolipoprotein L1.
Sharma AK; Friedman DJ; Pollak MR; Alper SL
FEBS J; 2016 May; 283(10):1846-62. PubMed ID: 26945671
[TBL] [Abstract][Full Text] [Related]
2. C-terminal mutants of apolipoprotein L-I efficiently kill both Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense.
Lecordier L; Vanhollebeke B; Poelvoorde P; Tebabi P; Paturiaux-Hanocq F; Andris F; Lins L; Pays E
PLoS Pathog; 2009 Dec; 5(12):e1000685. PubMed ID: 19997494
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein L1 Variant Associated with Increased Susceptibility to Trypanosome Infection.
Cuypers B; Lecordier L; Meehan CJ; Van den Broeck F; Imamura H; Büscher P; Dujardin JC; Laukens K; Schnaufer A; Dewar C; Lewis M; Balmer O; Azurago T; Kyei-Faried S; Ohene SA; Duah B; Homiah P; Mensah EK; Anleah F; Franco JR; Pays E; Deborggraeve S
mBio; 2016 Apr; 7(2):e02198-15. PubMed ID: 27073096
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the primate trypanolytic factor APOL1.
Thomson R; Genovese G; Canon C; Kovacsics D; Higgins MK; Carrington M; Winkler CA; Kopp J; Rotimi C; Adeyemo A; Doumatey A; Ayodo G; Alper SL; Pollak MR; Friedman DJ; Raper J
Proc Natl Acad Sci U S A; 2014 May; 111(20):E2130-9. PubMed ID: 24808134
[TBL] [Abstract][Full Text] [Related]
5. [Molecular dialogue between African trypanosomes and humans].
Pays E
Bull Mem Acad R Med Belg; 2011; 166(10-12):358-63; discussion 364-5. PubMed ID: 23082501
[TBL] [Abstract][Full Text] [Related]
6. Mutual self-defence: the trypanolytic factor story.
Pays E; Vanhollebeke B
Microbes Infect; 2008 Jul; 10(9):985-9. PubMed ID: 18675374
[TBL] [Abstract][Full Text] [Related]
7. Protein domains of APOL1 and its risk variants.
Lan X; Wen H; Lederman R; Malhotra A; Mikulak J; Popik W; Skorecki K; Singhal PC
Exp Mol Pathol; 2015 Aug; 99(1):139-44. PubMed ID: 26091559
[TBL] [Abstract][Full Text] [Related]
8. Exon 4-encoded sequence is a major determinant of cytotoxicity of apolipoprotein L1.
Khatua AK; Cheatham AM; Kruzel ED; Singhal PC; Skorecki K; Popik W
Am J Physiol Cell Physiol; 2015 Jul; 309(1):C22-37. PubMed ID: 25924622
[TBL] [Abstract][Full Text] [Related]
9. Localization of serum resistance-associated protein in Trypanosoma brucei rhodesiense and transgenic Trypanosoma brucei brucei.
Bart JM; Cordon-Obras C; Vidal I; Reed J; Perez-Pastrana E; Cuevas L; Field MC; Carrington M; Navarro M
Cell Microbiol; 2015 Oct; 17(10):1523-35. PubMed ID: 25924022
[TBL] [Abstract][Full Text] [Related]
10. Sequencing rare and common APOL1 coding variants to determine kidney disease risk.
Limou S; Nelson GW; Lecordier L; An P; O'hUigin CS; David VA; Binns-Roemer EA; Guiblet WM; Oleksyk TK; Pays E; Kopp JB; Winkler CA
Kidney Int; 2015 Oct; 88(4):754-63. PubMed ID: 25993319
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein L-I is the trypanosome lytic factor of human serum.
Vanhamme L; Paturiaux-Hanocq F; Poelvoorde P; Nolan DP; Lins L; Van Den Abbeele J; Pays A; Tebabi P; Van Xong H; Jacquet A; Moguilevsky N; Dieu M; Kane JP; De Baetselier P; Brasseur R; Pays E
Nature; 2003 Mar; 422(6927):83-7. PubMed ID: 12621437
[TBL] [Abstract][Full Text] [Related]
12. Coupling of lysosomal and mitochondrial membrane permeabilization in trypanolysis by APOL1.
Vanwalleghem G; Fontaine F; Lecordier L; Tebabi P; Klewe K; Nolan DP; Yamaryo-Botté Y; Botté C; Kremer A; Burkard GS; Rassow J; Roditi I; Pérez-Morga D; Pays E
Nat Commun; 2015 Aug; 6():8078. PubMed ID: 26307671
[TBL] [Abstract][Full Text] [Related]
13. A Primate APOL1 Variant That Kills Trypanosoma brucei gambiense.
Cooper A; Capewell P; Clucas C; Veitch N; Weir W; Thomson R; Raper J; MacLeod A
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004903. PubMed ID: 27494254
[TBL] [Abstract][Full Text] [Related]
14. APOL1 expression is induced by Trypanosoma brucei gambiense infection but is not associated with differential susceptibility to sleeping sickness.
Ilboudo H; Berthier D; Camara M; Camara O; Kabore J; Leno M; Keletigui S; Chantal I; Jamonneau V; Belem AM; Cuny G; Bucheton B
Infect Genet Evol; 2012 Oct; 12(7):1519-23. PubMed ID: 22691369
[TBL] [Abstract][Full Text] [Related]
15. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
Genovese G; Friedman DJ; Ross MD; Lecordier L; Uzureau P; Freedman BI; Bowden DW; Langefeld CD; Oleksyk TK; Uscinski Knob AL; Bernhardy AJ; Hicks PJ; Nelson GW; Vanhollebeke B; Winkler CA; Kopp JB; Pays E; Pollak MR
Science; 2010 Aug; 329(5993):841-5. PubMed ID: 20647424
[TBL] [Abstract][Full Text] [Related]
16.
Cooper A; Ilboudo H; Alibu VP; Ravel S; Enyaru J; Weir W; Noyes H; Capewell P; Camara M; Milet J; Jamonneau V; Camara O; Matovu E; Bucheton B; MacLeod A
Elife; 2017 May; 6():. PubMed ID: 28537557
[TBL] [Abstract][Full Text] [Related]
17. Human trypanolytic factor APOL1 forms pH-gated cation-selective channels in planar lipid bilayers: relevance to trypanosome lysis.
Thomson R; Finkelstein A
Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2894-9. PubMed ID: 25730870
[TBL] [Abstract][Full Text] [Related]
18. Distinct APOL1 functions in trypanosomes and kidney podocytes.
Pays E
Trends Parasitol; 2022 Feb; 38(2):104-108. PubMed ID: 34887168
[TBL] [Abstract][Full Text] [Related]
19. APOL1 nephropathy: from gene to mechanisms of kidney injury.
Kruzel-Davila E; Wasser WG; Aviram S; Skorecki K
Nephrol Dial Transplant; 2016 Mar; 31(3):349-58. PubMed ID: 25561578
[TBL] [Abstract][Full Text] [Related]
20. African trypanosomes: intracellular trafficking of host defense molecules.
Shiflett AM; Faulkner SD; Cotlin LF; Widener J; Stephens N; Hajduk SL
J Eukaryot Microbiol; 2007; 54(1):18-21. PubMed ID: 17300512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
